510(k) Report

510(k) · Cleared

Recalled · 2003

Axsym Tricyclic Antidepressants

K953761510(k) TraditionalCleared Nov 22, 1995103-day reviewClass II21 CFR 862.3910Recalls 2

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Abbott Laboratories · LFH U.V. Spectrometry, Tricyclic Antidepressant Drugs

Cleared on Nov 22, 1995 after a 103-day review. FDA has not posted a summary or statement for it, so its predicates are not known. It has been recalled 2 times.

Decided
Nov 22, 1995
Review
103 days
Class
Class II
Product code
LFH
Recalls
2
Predicates
0

FDA has not posted a summary or statement for it, so its predicates are not known.

FIG. 1 — Lineage of K953761Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LFH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LFH device

  1. #1 K213875 DRI TM Tricyclics Serum Tox Assayscore 7.5 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA has not posted a summary or statement for it, so its predicates are not known.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Nov 17, 2003Not classifiedZ-0323-04OtherDrug product cross reacts with the Tricyclic Antidepressants (TCA) assay.
Dec 11, 2002Not classifiedZ-0689-03OtherUnexpected false positive TCA results

No ancestor or descendant has a Class I recall.

How does its category compare?

All LFH devices

LFH U.V. Spectrometry, Tricyclic Antidepressant Drugs: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LFH

1in 2023

2022: 12023: 1
2007high 1 (2022) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LFH

Too few LFH 510(k)s in any year since 2007 to give a median.

Recalls per year · LFH

No recall names LFH since 2007.

Adverse event reports per year · LFH

1in 2007

2007: 1
2007high 1 (2007) · low 0 (2008)2025

MAUDE reports naming product code LFH, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—01
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20221—00
20231—00
20240—00
20250—00
20260—0—
Cite this page

510(k) Report. “K953761: Axsym Tricyclic Antidepressants.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K953761

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026